Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jungshan Chang is active.

Publication


Featured researches published by Jungshan Chang.


Nature Medicine | 2009

Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury

Andrés Hidalgo; Jungshan Chang; Jung Eun Jang; Anna Peired; Elaine Y. Chiang; Paul S. Frenette

Selectins and their ligands mediate leukocyte rolling, allowing interactions with chemokines that lead to integrin activation and arrest. Here we show that E-selectin is crucial for generating a secondary wave of activating signals, transduced specifically by E-selectin ligand-1, that induces polarized, activated αMβ2 integrin clusters at the leading edge of crawling neutrophils, allowing capture of circulating erythrocytes or platelets. In a humanized mouse model of sickle cell disease, the capture of erythrocytes by αMβ2 microdomains leads to acute lethal vascular occlusions. In a model of transfusion-related acute lung injury, polarized neutrophils capture circulating platelets, resulting in the generation of oxidative species that produce vascular damage and lung injury. Inactivation of E-selectin or αMβ2 prevents tissue injury in both inflammatory models, suggesting broad implications of this paradigm in thromboinflammatory diseases. These results indicate that endothelial selectins can influence neutrophil behavior beyond its canonical rolling step through delayed, organ-damaging, polarized activation.


Journal of Experimental Medicine | 2005

CD44 is a physiological E-selectin ligand on neutrophils

Yoshio Katayama; Andrés Hidalgo; Jungshan Chang; Anna Peired; Paul S. Frenette

The selectin family of adhesion molecules and their glycoconjugated ligands are essential for blood polymorphonuclear neutrophil (PMN) extravasation into inflammatory and infectious sites. However, E-selectin ligands on PMNs are not well characterized. We show here that CD44 immunopurified from G-CSF–differentiated 32D cells or from peripheral blood PMNs binds specifically to E-selectin. In contrast, CD44 extracted from bone marrow stromal or brain endothelial cell lines does not interact with E-selectin, suggesting cell-specific posttranslational modifications of CD44. PMN-derived CD44 binding activity is mediated by sialylated, α(1,3) fucosylated, N-linked glycans. CD44 enables slow leukocyte rolling on E-selectin expressed on inflamed endothelium in vivo and cooperates with P-selectin glycoprotein ligand–1 to recruit neutrophils into thioglycollate-induced peritonitis and staphylococcal enterotoxin A–injected skin pouch. CD44 extracted from human PMNs also binds to E-selectin. Moreover, we demonstrate that CD44 is hypofucosylated in PMNs from a patient with leukocyte adhesion deficiency type II, suggesting that it contributes to the syndrome. These findings thus suggest broader roles for CD44 in the innate immune response and uncover a potential new target for diseases in which selectins play a prominent role.


Blood | 2010

GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice

Jungshan Chang; John T. Patton; Arun K. Sarkar; Beat Ernst; John L. Magnani; Paul S. Frenette

Leukocyte adhesion in the microvasculature influences blood rheology and plays a key role in vaso-occlusive manifestations of sickle cell disease. Notably, polymorphonuclear neutrophils (PMNs) can capture circulating sickle red blood cells (sRBCs) in inflamed venules, leading to critical reduction in blood flow and vaso-occlusion. Recent studies have suggested that E-selectin expression by endothelial cells plays a key role by sending activating signals that lead to the activation of Mac-1 at the leading edge of PMNs, thereby allowing RBC capture. Thus, the inhibition of E-selectin may represent a valuable target in this disease. Here, we have tested the biologic properties of a novel synthetic pan-selectin inhibitor, GMI-1070, with in vitro assays and in a humanized model of sickle cell vaso-occlusion analyzed by intravital microscopy. We have found that GMI-1070 predominantly inhibited E-selectin-mediated adhesion and dramatically inhibited sRBC-leukocyte interactions, leading to improved microcirculatory blood flow and improved survival. These results suggest that GMI-1070 may represent a valuable novel therapeutic intervention for acute sickle cell crises that should be further evaluated in a clinical trial.


Nature Methods | 2007

Imaging receptor microdomains on leukocyte subsets in live mice

Elaine Y. Chiang; Andrés Hidalgo; Jungshan Chang; Paul S. Frenette

We present a simple method to identify the recruitment of leukocyte subsets and determine concurrent surface-receptor clustering in live mice. We show that CD45+ F4/80− Gr-1+ neutrophils are robustly recruited in surgery-activated cremasteric venules, whereas adherent CD45+ B220+ B lymphocytes were dominant in bone marrow venules. Most adherent Gr-1+ leukocytes are not firmly stationary but actively migrate on TNF-α–activated cremasteric venular endothelium and exhibit marked polarization of surface PSGL-1, but not LFA-1, to the trailing edge.


Blood | 2008

Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion.

Jungshan Chang; Patricia A. Shi; Elaine Y. Chiang; Paul S. Frenette


Blood | 2008

Effects of Pan-Selectin Antagonist GMI-1070 on the Treatment of Vaso-Occlusion in Sickle Cell Mice

Jungshan Chang; John T. Patton; Paul S. Frenette; John L. Magnani


Blood | 2007

A Novel Selectin Antagonist, GMI-1070, Prevents Vaso-Occlusion in Sickle Cell Mice by Inhibiting Leukocyte Adhesion and Activation.

Jungshan Chang; John T. Patton; Arun K. Sarkar; John L. Magnani; Paul S. Frenette


Archive | 2012

occlusions in sickle cell mice GMI-1070, a novel pan-selectin antagonist, reverses acute vascular

Jungshan Chang; John T. Patton; Arun K. Sarkar; Beat Ernst; John L. Magnani; Paul S. Frenette


Blood | 2008

Contributions of Immune Cells to Vascular Occlusion in Sickle Cell Disease.

Paul S. Frenette; Andrés Hidalgo; Jungshan Chang; Anna Peired


Blood | 2007

Sickle Cell Vaso-Occlusion Is Triggered by E-Selectin Ligand Signaling and Propagated by the Leukocyte Integrin Mac-1.

Andrés Hidalgo; Jungshan Chang; Anna Peired; Elaine Y. Chiang; Paul S. Frenette

Collaboration


Dive into the Jungshan Chang's collaboration.

Top Co-Authors

Avatar

Paul S. Frenette

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Andrés Hidalgo

Centro Nacional de Investigaciones Cardiovasculares

View shared research outputs
Top Co-Authors

Avatar

Elaine Y. Chiang

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Arun K. Sarkar

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

John L. Magnani

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Anna Peired

University of Florence

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jung Eun Jang

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

Patricia A. Shi

Icahn School of Medicine at Mount Sinai

View shared research outputs
Researchain Logo
Decentralizing Knowledge